Research is being conducted on adoptive cell therapy for cancer, focusing on combination strategies and biomarkers. Studies are exploring various aspects of immunotherapy, including overcoming T cell exhaustion, immune evasion, and resistance to immune checkpoint inhibitors, across different types of cancer. The investigations aim to improve the efficacy of immunotherapy in cancers such as ovarian, breast, bladder, and gastric cancer.